$27 Billion Take-Private Wave as Penske, CCC Lead Deal Frenzy; Bank Earnings Beat Estimates Despite Margin Pressures

Mumbai, 17 Oct: The week’s trading session witnessed transformative corporate developments across US equity markets, with take-private transactions valued at approximately $27 billion, quarterly earnings from major financial institutions exceeding consensus estimates, and significant capital-raising activity across healthcare, technology and defence sectors. The week’s developments highlighted evolving dynamics in banking profitability, private equity deployment and sector-specific growth trajectories.

Penske’s $16.3 Billion Take-Private Reshapes Automotive Retail Landscape

Penske Automotive Group (NYSE: PAG) agreed to be acquired by Motown Acquisition Corp., an entity controlled by Penske Corporation and Mitsui & Co., in a transaction valuing the automotive dealership group at approximately $16.3 billion in enterprise value. The $212 per share cash offer represented an 8.84% premium to the prior closing price of $194.79.

The transaction, not subject to financing conditions, is expected to close in the first quarter of 2027. Penske Corporation’s existing ownership stake and Mitsui’s strategic partnership positioned the deal as a consolidation of long-term shareholders rather than an external buyout. Penske Automotive shares rose 8.84% to close at $212.00, trading between $210.51 and $212.19 during the session.

Also Read: What Is the New York Stock Exchange (NYSE)?  

The take-private structure allows Penske Automotive to pursue its multi-year strategy across automotive retail, commercial truck operations and vehicle financing without quarterly public market scrutiny. The company operates dealerships across the United States, United Kingdom, Canada, Germany, Italy and Japan.

CCC Intelligent Solutions’ $4.9 Billion Buyout Delivers 44% Premium to Shareholders

CCC Intelligent Solutions Holdings (NASDAQ: CCC) entered a definitive agreement to be acquired by a consortium led by GTCR LLC and Elliott Investment Management for approximately $4.9 billion in an all-cash transaction. Shareholders will receive $7.75 per share, representing a 44% premium to the unaffected closing price on 9 July 2026 and a 59% premium to the 30-day average price.

The transaction includes termination fees of $149.52 million payable by CCC and $313.99 million payable by the acquiring consortium. CCC Chairman and CEO Githesh Ramamurthy and President Tim Welsh entered rollover and support agreements. The deal is expected to close in the first quarter of 2027, subject to regulatory approvals.

CCC shares traded flat at approximately $7.63, reflecting the narrow spread to the offer price and high deal certainty. The intraday range was $7.59 to $7.65, with volume reaching approximately 324 million shares. CCC provides cloud-based software connecting more than 35,000 businesses across the property and casualty insurance ecosystem.

Iambic Therapeutics’ $150 Million IPO Debuts 15.6% Higher on AI Drug Discovery Platform

Iambic Therapeutics (NASDAQ: IAM) began trading on the Nasdaq Global Select Market on 15 October, opening at $16.15 and surging to an intraday high of $19.70. The IPO priced at $16.00 per share on 14 October, raising $150 million in gross proceeds from the sale of 9.375 million shares. The stock closed at approximately $18.49, up 15.6% from the IPO price.

Also Read: How to invest in US stocks 

Underwriters received a 30-day option to purchase up to 1.41 million additional shares. Market value at pricing was approximately $809 million. The San Diego-based company plans to use proceeds to advance three early-stage cancer drug candidates, leveraging artificial intelligence and machine learning to identify novel therapies.

The successful debut indicated continued appetite for AI-enabled healthcare investments, although the company remains clinical-stage with no approved products and will require additional financing to fund development programmes.

Charles Schwab Reports Record Revenue but Shares Fall 2.9% on Deposit Concerns

Charles Schwab Corporation (NYSE: SCHW) reported record net revenue of $7.2 billion, with adjusted earnings per share of $1.69, up 29% year-over-year. However, total net revenue of $7.17 billion slightly missed the $7.19 billion consensus estimate. GAAP EPS was $1.62, while adjusted EPS beat the $1.66 consensus.

Net income reached $2.9 billion. Core net new assets totalled $190 billion, up 38% year-over-year, and managed investing net flows hit a record $24 billion. Total client assets reached $13.3 trillion. Despite the earnings beat, shares declined approximately 2.9% as investors focused on the revenue miss and deposit trends.

The Westlake, Texas-based company provides wealth management, securities brokerage, banking, asset management and custody services. The deposit decline raised questions about Schwab’s ability to monetise client cash in a changing interest rate environment.

BNY Mellon Beats Estimates on 12% Revenue Growth and Strong Fee Income

Bank of New York Mellon Corporation (NYSE: BNY) reported adjusted EPS of $2.37 versus the $2.26 consensus, while GAAP EPS was $2.34, up 24% year-over-year. Total revenue reached $5.7 billion, up 12% year-over-year, driven by broad-based segment growth and positive operating leverage.

Pre-tax margin was 39%, and net income totalled $1.69 billion. Assets under custody and administration reached $63.4 trillion. Management confirmed full-year guidance pointing to 15% year-over-year growth. Shares rose in pre-market trading following the beat.

The New York-based company provides investment management, investment services and wealth management to institutions, corporations and high-net-worth individuals.

PNC Financial Beats on Adjusted EPS as Revenue Slightly Misses

PNC Financial Services Group (NYSE: PNC) reported net income of $2.1 billion, or $4.97 diluted EPS ($5.09 adjusted), beating the $4.91 consensus. Revenue of $6.56 billion missed the $6.61 billion estimate. Total revenue rose 9.7% year-over-year.

Return on tangible common equity was 18.3%. Strong profitability metrics offset revenue concerns, with management citing substantial client momentum. Shares showed modest positive movement following the results. The Pittsburgh-based company provides banking, investment and asset management services across the United States.

U.S. Bancorp Reports Record Revenue and Raises Full-Year Guidance

U.S. Bancorp (NYSE: USB) reported record net revenue of $7.97 billion, up 8.7% year-over-year, with diluted EPS of $1.34, beating the $1.32 consensus. The company raised its full-year outlook. Net revenue represented 8.7% year-over-year growth, or 6.4% adjusting for BTIG and securities losses.

Also Read: US Stock Market Timings

Net interest income rose 5.6%, while fee revenue surged 14.9%. A reserve build impacted EPS by approximately $0.07. Credit quality remained stable. The combination of record revenue, fee income surge and raised guidance signalled strong fundamental momentum. Shares rose in pre-market trading. The Minneapolis-based company offers banking, investment, mortgage, trust and payment services.

JPMorgan Posts $15.3 Billion Profit Despite Earnings Miss; Citigroup, Wells Fargo Report Mixed Results

JPMorgan Chase & Co. reported net income of $15.3 billion for the third quarter of 2026, alongside a 20% return on tangible common equity. However, adjusted earnings per share of $5.75 fell short of the $5.93 consensus estimate. Managed revenue rose 8% year-over-year to $50.9 billion, supported by growth across consumer banking, investment banking, markets and wealth management.

Net interest income increased 13% year-over-year to $27.1 billion, while noninterest revenue reached $23.8 billion, up 3%. Expenses climbed 12% to $27.3 billion, reflecting higher compensation, technology spending and distribution costs. Credit costs totalled $2.7 billion, including $2.2 billion in net charge-offs and a $539 million net reserve build. The bank maintained a standardised Common Equity Tier 1 ratio of 13.9% and total liquidity resources of $1.5 trillion. JPMorgan shares traded at $336.31, up 0.62% from the previous close of $334.23.

Citigroup Inc. reported adjusted earnings per share rising 27% year-over-year to $2.85, exceeding the $2.66 consensus. Revenue increased 8% to approximately $23.8 billion, while net income reached $5.2 billion. Services and wealth management were key contributors, with both businesses recording 15% revenue growth to $6.6 billion and $3.3 billion, respectively.

Citigroup’s return on equity improved to 10.1%, while return on tangible common equity reached 11.5%. Average loans rose 12% to $809 billion, and deposits increased 9% to approximately $1.5 trillion. Despite the earnings beat, Citigroup shares declined 3.21% to $127.84.

Wells Fargo & Company reported a 13% year-over-year increase in third-quarter earnings, with earnings per share reaching $1.87, above the $1.84 consensus. However, revenue of $21.87 billion fell short of the $22.31 billion forecast. Net interest income increased 5% year-over-year, adding $567 million, while average loans and deposits each grew 11%. Wells Fargo shares traded at $82.10, down 1.48% from the previous close of $83.32.

Goldman Sachs Posts Second-Highest Quarterly Revenue as Investment Banking Advisory Fees Surge

Goldman Sachs Group Inc. reported earnings per share of $17.01 against the $13.09 consensus, with revenue totalling $18.68 billion, exceeding the $16.86 billion forecast and marking the second-highest quarterly revenue in the bank’s history. Investment banking advisory revenue increased 18% year-over-year to $1.7 billion, while equities revenue surged 72% to $6.4 billion.

Assets under supervision reached a record $4.1 trillion, and wealth management client assets climbed to $2.1 trillion. Return on equity stood at 18.7%, while return on tangible equity reached 20.5%. Management raised its full-year alternative investments fundraising target to approximately $150 billion, up from the previous range of $75 billion to $100 billion.

Goldman increased its quarterly dividend to $5 per share, a 25% rise from a year earlier. Shares traded at $899.27, up 0.60% from the previous close of $893.95.

Morgan Stanley Beats Estimates on Equity Trading Strength but Shares Decline 3.55%

Morgan Stanley (NYSE: MS) reported revenue rising 11.6% year-over-year to $20.34 billion, surpassing the $19.92 billion consensus, while earnings reached $3.03 per share, above the $2.92 estimate. The Institutional Securities division benefited from a 41% annual increase in equity trading revenue to $5.8 billion.

Also Read: What Are Fractional Shares? 

Wealth Management generated record revenue of $9.1 billion, up 10% year-over-year, and attracted $232 billion in net new assets. Investment Banking revenue increased 2% to $2.2 billion. However, Fixed Income trading revenue declined 7% to $2 billion, and Investment Management revenue fell 12% to $1.5 billion.

Net income increased to $4.9 billion from $4.6 billion a year earlier. The firm reported a 22.6% return on tangible common equity and a 14.9% Standardised Common Equity Tier 1 capital ratio. Despite the earnings beat, Morgan Stanley shares declined 3.55% to $180.01.

UnitedHealth Raises Guidance to $20.50 as Medical Care Ratio Improves

UnitedHealth Group reported adjusted earnings per share of $4.69, up from $2.92 a year earlier and above the $4.12 consensus. Revenue totalled $112.7 billion, exceeding the $111.31 billion estimate. The company raised its full-year adjusted earnings guidance to at least $20.50 per share.

The medical care ratio improved to 88.4% from 89.9% a year earlier, indicating better control over medical costs. Management attributed progress to improved execution across UnitedHealthcare insurance and Optum services businesses. The company reported $5 billion in share repurchases through the third quarter and $6.2 billion in dividends paid year-to-date. UnitedHealth shares were quoted at $382.24, up 1.01% from the previous close of $378.52.

Johnson & Johnson Raises EPS Outlook to $11.10 Despite MedTech Sales Shortfall

Johnson & Johnson reported third-quarter revenue of $25.4 billion, exceeding the $25.28 billion estimate, while adjusted earnings reached $2.59 per share, beating expectations by $0.05. Pharmaceutical sales increased 7.7% to $16.76 billion, supported by strong demand for Tremfya, which rose 68% to $2.4 billion.

However, medical technology division sales growth of 2.5% to $8.6 billion fell below the $8.71 billion forecast. Management cited pressure from geopolitical tensions in the Middle East, European austerity measures and pricing conditions in China. Johnson & Johnson raised its full-year sales forecast to approximately $101.2 billion and increased adjusted earnings guidance midpoint to $11.10 per share.

The company declared a quarterly cash dividend of $1.34 per share, payable on 8 December 2026. Shares traded at $247.83, down approximately 6.05% from the previous close of $263.79.

BlackRock Beats Estimates as AUM Reaches $15.5 Trillion

BlackRock (NYSE: BLK) reported earnings per share of $15.93, above the $14.30 estimate. Revenue increased 19% year-over-year to $7.75 billion, surpassing the $7.44 billion forecast. Net inflows totalled $205 billion, while assets under management rose to $15.5 trillion.

Also Read: What is NASDAQ Composite 

Operating income climbed 27% to $3.3 billion, and the operating margin expanded 320 basis points to 47.8%. Earnings per share increased 38%, supported by growth across exchange-traded funds, fixed income, private markets and technology services. Net inflows over the past 12 months approached $870 billion.

Management expects 30%-40% of annual iShares inflows in the fourth quarter and anticipates at least $550 million in share repurchases. BlackRock shares rose 2.71% to $1,095 in premarket trading.

Fastenal Q3 Earnings Grow 19.8% on Digital Sales Growth

Fastenal Company reported adjusted earnings of $0.35 per share, exceeding the $0.34 estimate. Net sales rose 15.5% year-over-year to $2.46 billion, ahead of the $2.44 billion forecast, while diluted earnings per share increased 19.8%.

Operating margin expanded 90 basis points to 21.5%, supported by disciplined expense management. Return on invested capital improved 230 basis points to 32.5%. Contract count increased 6.4% to 3,744, while sales from customer sites spending at least $50,000 monthly surged 27.6%. Fastenal shares rose 1.03% to $51.95.

Copart Completes $10.50 Per Share Acquisition of ACV Auctions

Copart, Inc. completed its acquisition of ACV Auctions Inc. following the expiration of the tender offer at 5:00 p.m. ET on 15 October 2026. A total of 116,818,409 shares of ACV common stock were validly tendered at $10.50 per share, representing approximately 68.43% of ACV’s outstanding shares.

The completion consolidates Copart’s position in the online vehicle auction market. ACV shares have ceased trading following completion. Copart shares were little changed on the news. The antitrust waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on 12 October.

Bank of America Faces $1.21 Billion Penalty as Compliance Failures Surface

The US Treasury announced more than $1.21 billion in penalties against Bank of America (NYSE: BAC) over anti-money-laundering failures and sanctions violations. The Financial Crimes Enforcement Network assessed a $1.2 billion penalty, while the Office of Foreign Assets Control settled 475 apparent sanctions violations for $11.6 million. The Office of the Comptroller of the Currency imposed a $750 million civil money penalty.

Bank of America’s third-quarter net income fell to $6.9 billion from $8.3 billion a year earlier. Excluding the charge, adjusted net income reached $8.1 billion. Revenue increased 3% to $30 billion, supported by higher interest income and wealth management fees.

Shares declined 1.17% on 13 October to close at $53.94, followed by a further 2.29% drop in after-hours trading to $52.73.

GlobalFoundries Selected for $21 Billion US-Japan Semiconductor Initiative

GlobalFoundries (NASDAQ: GFS) has been selected to provide technology and operate two new semiconductor manufacturing facilities in Malta, New York, under a US-Japan initiative backed by up to $21 billion in Japanese investment. An initial investment of approximately $10 billion will fund a new 300mm fab expected to begin operations in 2029, with a further $10 billion potentially supporting a second facility.

Each fab is expected to add approximately 900,000 wafers of annual US manufacturing capacity. The development is projected to generate about 27,000 construction and ecosystem jobs and more than 1,000 skilled manufacturing positions. Separately, GlobalFoundries agreed with the US Department of Commerce to reallocate $955 million from its existing CHIPS and Science Act award to accelerate investments in silicon photonics and advanced packaging. GlobalFoundries shares traded at $48.72.

RTX Wins $8 Billion Air Force Contract for Strategic Communications Modernisation

RTX Corp. subsidiary Raytheon secured an $8 billion maximum-ceiling contract to modernise strategic communications terminals overseen by the US Air Force Nuclear Weapons Centre. The agreement covers developmental modernisation, production restart services and technical studies.

The contract was awarded on a sole-source basis, with $800,000 in fiscal 2026 research, development, test and evaluation funding obligated at the time of award. Work will be carried out in Marlborough, Massachusetts, and Largo, Florida, and is expected to continue through 12 October 2036. RTX shares traded at $186.13, up approximately 1.07% from the previous close of $184.16.

IonQ Announces $1.3 Billion Elisity Acquisition and $2 Billion Equity Offering

IonQ Inc. (NYSE: IONQ) agreed to acquire Zero Trust cybersecurity provider Elisity Inc. in an all-stock transaction valued at up to $1.3 billion, including performance-based earnouts of up to $150 million. The acquisition aims to expand IonQ’s enterprise cybersecurity business ahead of the transition to post-quantum cryptography.

Separately, IonQ priced a $2 billion equity offering with an entity managed by Heights Capital Management. The deal includes 20.5 million common shares at $40 each and pre-funded warrants for 29.5 million shares. The company also issued seven-year warrants to purchase 100 million additional shares at an exercise price of $69.46. IonQ shares traded at $31.36, down 9.72%.

SSR Mining to Acquire Roxmore Resources for $464 Million

SSR Mining Inc. agreed to acquire Roxmore Resources Inc. for approximately $464 million in cash, expanding its Nevada operations through the Converse Gold Project. Roxmore shareholders will receive C$6.75 per share, representing a 27% premium to the 9 October closing price.

Located six kilometres from SSR Mining’s Marigold Complex, Converse reported 2.2 million ounces of indicated gold resources and 3 million ounces of inferred resources. SSR Mining expects the project could eventually produce 150,000 to 170,000 ounces of gold annually over an estimated 10-year mine life, with initial production targeted for 2033. SSR Mining shares traded at $32.73, down 7.65%.

Venture Global Signs $17.2 Billion Power Framework Agreements

Venture Global (NYSE: VG) signed framework agreements with GE Vernova and Baker Hughes Energy Services for power generation and grid equipment supporting its LNG infrastructure. The agreements have a potential combined value of approximately $17.2 billion and cover up to 16 new power island units.

The arrangements support expansion of Venture Global’s existing grid-independent power network. Shares declined approximately 4.1% as investors considered the scale of potential investment and implications for spending and financing.

Capital Raising Surges to $4.2 Billion as SentinelOne’s $1.25 Billion Notes and Strive’s $630 Million Preferred IPO Dominate Week

The week witnessed a substantial wave of capital raising activity across healthcare, technology and energy sectors, with companies collectively announcing or pricing approximately $4.2 billion in equity and debt offerings. The fundraisings served varied purposes, from financing acquisitions and data centre expansion to shoring up balance sheets and funding clinical development programmes, with market reactions ranging from sharp declines on dilution concerns to modest gains on strategic clarity.

SentinelOne Inc. (NYSE: S) announced plans to privately offer $1.25 billion in zero-interest convertible senior notes due 2031 to qualified institutional buyers. The cybersecurity firm may also allow initial purchasers to acquire an additional $187.5 million in notes under an option exercisable within 13 days of initial issuance. Proceeds are intended to fund privately negotiated capped call transactions, repurchase up to $150 million of Class A common stock and support general corporate purposes, including working capital, capital expenditure and potential acquisitions. The capped call arrangements are designed to reduce potential shareholder dilution if the notes are converted into shares. Separately, the company plans to establish a $400 million secured revolving credit facility. Shares traded at $24.86, down 2.61%, as investors assessed potential dilution and capital allocation implications.

Cipher Digital Inc. (NASDAQ: CIFR) proposed an $850 million convertible senior notes offering alongside an exchange of existing debt securities for common shares, raising concerns about financing costs and potential dilution. Its Black Pearl campus began generating rent in August, while Barber Lake is expected to start generating rental income in October. Shares traded at $11.50, down 11.42%, reflecting the market’s negative response to the proposed financing structure.

Select Water Solutions Inc. (NYSE: WTTR) proposed an $800 million senior notes offering maturing in 2034. The proceeds are intended to help finance its acquisition of Pilot Water Solutions, refinance existing debt and cover transaction costs. If the acquisition does not close by 1 March 2027, Select Water Holdings will be required to redeem more than $450 million in notes at the issue price plus interest. The acquisition is expected to expand the company’s water management services for oil and gas operations.

Digi Power X Inc. (NASDAQ: DGXX) secured a commitment for US$200 million in debt financing to support its 40-megawatt Alabama AI data centre. Syndicated by Goldman Sachs, the financing is expected to close within 90 days, subject to due diligence and other conditions. The company said the funding would help complete the project while preserving corporate liquidity and limiting shareholder dilution. Shares traded at approximately $3.055, up 1.16%. Phase 1 is expected to be completed in December 2026, followed by Phase 2 in March 2027.

Verastem Oncology (NASDAQ: VSTM) priced an underwritten public offering of 30,937,500 common shares at $8 each, targeting gross proceeds of approximately $250 million. The company also offered pre-funded warrants for up to 312,503 shares at $7.9999 per warrant. Proceeds will support clinical development of drug candidates, including the VS-7375 programme, alongside working capital. Shares traded at $7.87, up 5.57%.

Recursion Pharmaceuticals (NASDAQ: RXRX) priced an underwritten public offering of 61.54 million Class A common shares at $3.25 each, expected to generate approximately $200 million. The price represented a discount to the previous closing price of $3.74, creating potential dilution for existing shareholders. Shares declined as investors assessed the impact of the discounted share issuance.

Strive, Inc. (NASDAQ: ASST) priced an upsized initial public offering of 7,000,000 shares of its 15.00% Series A Perpetual SATS Preferred Stock at $90 per share, raising approximately $630 million in gross proceeds. The offering was upsized by 2,000,000 shares over the previously announced amount. Proceeds will be used for general corporate purposes, including bitcoin acquisition, purchase of income-generating assets, working capital and potential buybacks of Class A common stock. Shares rose 3.93% to $25.65.

Winmark’s $4.00 Special Dividend Sparks 7.28% Surge as P&G Extends 136-Year Payout Streak

The week witnessed a series of shareholder return announcements across consumer goods, retail and energy sectors, with companies declaring dividends, launching buyback programmes and establishing formal capital return frameworks. The combined value of announced distributions and repurchases exceeded $350 million, reflecting continued emphasis on returning capital to shareholders amid varying operational conditions.

Procter & Gamble Company (NYSE: PG) declared a quarterly dividend of $1.0885 per common share, payable on or after 16 November to shareholders of record at the close of business on 23 October. The declaration also covers Series A and Series B ESOP Convertible Class A Preferred Stock. P&G has paid dividends for 136 consecutive years since its incorporation in 1890 and increased its dividend for 70 consecutive years, underscoring its long-standing shareholder distribution record. Shares traded around $153.05, with an indicated dividend yield of approximately 2.84%.

Winmark Corporation (NASDAQ: WINA) announced a quarterly cash dividend of $1.02 per share and a special dividend of $4.00 per share, both payable on 1 December 2026 to shareholders of record on 11 November. The special dividend totals approximately $14.2 million and is expected to be funded from cash on hand. Chief Executive Brett D. Heffes said the company is retaining higher cash reserves to provide flexibility for share repurchases and address $60 million in debt maturities over the next 30 months. Shares rose 7.28% to $302.94, reflecting the market’s positive response to the combined payout.

SkyAI (NASDAQ: SKYA) announced plans for a $201 million share buyback through a tender offer, offering $3 per share for up to 95% of outstanding shares and warrants. The company sold half of its Solana treasury to fund the repurchase. SkyAI suspended its existing share repurchase programme and said it would not purchase shares outside the tender offer until at least 10 business days after the offer expires. The tender offer was scheduled to commence around 15 October 2026.

AIR Global PLC (NASDAQ: AIIR) established a formal capital return framework, including an annual dividend of $0.28 per share and a $100 million share buyback programme. Shares traded at $7.50, up 0.27%. The framework signals the company’s commitment to consistent shareholder distributions while maintaining flexibility for growth investments.

Antero Midstream (NYSE: AM) declared a cash dividend of $0.225 per share for Q3 2026, payable on 11 November to stockholders of record as of 28 October. The company also repurchased 1.3 million shares during the quarter, continuing its programme of returning capital through both dividends and buybacks.

The week’s $27 billion in take-private transactions, led by Penske Automotive and CCC Intelligent Solutions, signalled robust private equity deployment across automotive retail and insurance technology. Bank earnings largely exceeded estimates, though revenue misses at Citigroup and Wells Fargo highlighted margin pressures. Iambic Therapeutics’ successful Nasdaq debut and Strive’s $630 million preferred offering demonstrated continued capital market access. GlobalFoundries’ $21 billion semiconductor initiative and RTX’s $8 billion defence contract underscored sector-specific growth trajectories. Monitoring regulatory approvals for pending acquisitions and fourth-quarter earnings guidance remains essential.